Fellow of The Academy of Medical Sciences, United Kingdom
Ajit Lalvani focuses on Immunology, Tuberculosis, Mycobacterium tuberculosis, Tuberculin and Virology. His Immunology research focuses on subjects like Cytotoxic T cell, which are linked to Epitope and Circumsporozoite protein. He interconnects ELISPOT, Internal medicine, T lymphocyte and Vaccination in the investigation of issues within Tuberculosis.
His studies in Mycobacterium tuberculosis integrate themes in fields like Vitamin D and neurology and Genotype. He focuses mostly in the field of Tuberculin, narrowing it down to topics relating to Tuberculosis diagnosis and, in certain cases, Nontuberculous mycobacteria. His research investigates the link between Virology and topics such as Plasmodium falciparum that cross with problems in Vaccine trial, Anopheles, Virus and Immunogenicity.
His scientific interests lie mostly in Tuberculosis, Immunology, Mycobacterium tuberculosis, Virology and Latent tuberculosis. Ajit Lalvani has included themes like Internal medicine, Incidence and Cohort in his Tuberculosis study. His study looks at the intersection of Mycobacterium tuberculosis and topics like Microbiology with Antiprotozoal.
The concepts of his Virology study are interwoven with issues in Tuberculosis vaccines, ESAT-6, Epitope and Cytotoxic T cell, CTL*. His Latent tuberculosis research integrates issues from Pediatrics, Family medicine and Mass screening. Ajit Lalvani focuses mostly in the field of Tuberculin, narrowing it down to matters related to T-SPOT.TB and, in some cases, CFP-10.
His primary scientific interests are in Tuberculosis, Latent tuberculosis, Internal medicine, Cohort and Mycobacterium tuberculosis. His Tuberculosis study combines topics from a wide range of disciplines, such as Immunology, Incidence and Cohort study. Ajit Lalvani merges Immunology with Cell type in his research.
His Latent tuberculosis research incorporates elements of Family medicine and Active tuberculosis. Ajit Lalvani is interested in Pyrazinamide, which is a field of Mycobacterium tuberculosis. His work in Tuberculin addresses issues such as Vaccination, which are connected to fields such as Mass screening, Coinfection and ELISPOT.
Tuberculosis, Latent tuberculosis, Incidence, Mycobacterium tuberculosis and Cohort are his primary areas of study. His Tuberculosis study integrates concerns from other disciplines, such as Prospective cohort study and Internal medicine. The Latent tuberculosis study which covers Family medicine that intersects with Risk stratification, Active tuberculosis, Immune profiling and Tumor necrosis factors.
Within one scientific family, he focuses on topics pertaining to Cohort study under Incidence, and may sometimes address concerns connected to Retrospective cohort study and Rate ratio. The study incorporates disciplines such as Immune system and Immunology in addition to Mycobacterium tuberculosis. Many of his studies on Immunology involve topics that are commonly interrelated, such as In vitro.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study
Robert J Wilkinson;Robert J Wilkinson;Martin Llewelyn;Zahra Toossi;Punita Patel.
The Lancet (2000)
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak
Katie Ewer;Jonathan Deeks;Lydia Alvarez;Gerry Bryant.
The Lancet (2003)
Rapid Effector Function in CD8+ Memory T Cells
Ajit Lalvani;Roger Brookes;Sophie Hambleton;Warwick J. Britton.
Journal of Experimental Medicine (1997)
Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells
Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson.
American Journal of Respiratory and Critical Care Medicine (2001)
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.
J Dinnes;J Deeks;H Kunst;A Gibson.
Health Technology Assessment (2007)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar;Shaima Begom;Alison Bermingham;Katja Hoschler.
Nature Medicine (2013)
Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis.
Valerie Guyot-Revol;John A. Innes;Sarah Hackforth;Tim Hinks.
American Journal of Respiratory and Critical Care Medicine (2006)
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells
Ajit Lalvani;Ansar A. Pathan;Helen Durkan;Katalin A. Wilkinson.
The Lancet (2001)
Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study.
Susan Liebeschuetz;Sheila Bamber;Katie Ewer;Jonathan Deeks.
The Lancet (2004)
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.
Ansar A. Pathan;Katalin A. Wilkinson;Paul Klenerman;Helen McShane.
Journal of Immunology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: